Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMANDA LEE HOWINGTON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1730506981
CMS profile
11224230
Location
NATCHEZ, MS

General Payments · PY2021–2024

$805.72

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$287.37

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $287.37 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Axsome Therapeutics, Inc. $80.82 3
NOVARTIS PHARMACEUTICALS CORPORATION $60.45 3
ITI, Inc. $53.66 3
Novo Nordisk AS $49.19 3
Amgen Inc. $22.25 1
Otsuka America Pharmaceutical, Inc. $21.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $69.80 4
PY2022 $175.78 10
PY2023 $272.77 15
PY2024 $287.37 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.25 05/23/2024 Food and Beverage Undisputed 01/23/2026 1117582679 CMS
Axsome Therapeutics, Inc. $32.99 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148332977 CMS
Axsome Therapeutics, Inc. $26.39 04/30/2024 Food and Beverage Undisputed 01/23/2026 1148332975 CMS
Axsome Therapeutics, Inc. $21.44 08/13/2024 Food and Beverage Undisputed 01/23/2026 1148332979 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.92 01/09/2024 Food and Beverage Undisputed 01/23/2026 1143505138 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.30 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143505145 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.44 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143505151 CMS
Novartis Pharmaceuticals Corporation $25.20 06/20/2024 Food and Beverage Undisputed 01/23/2026 1086947747 CMS
Novartis Pharmaceuticals Corporation $19.65 07/03/2024 Food and Beverage Undisputed 01/23/2026 1086947753 CMS
Novartis Pharmaceuticals Corporation $15.60 09/11/2024 Food and Beverage Undisputed 01/23/2026 1086947759 CMS
Novo Nordisk Inc $20.27 03/21/2024 Food and Beverage Undisputed 01/23/2026 1100243969 CMS
Novo Nordisk Inc $13.99 07/09/2024 Food and Beverage Undisputed 01/23/2026 1100487141 CMS
Novo Nordisk Inc $14.93 12/04/2024 Food and Beverage Undisputed 01/23/2026 1100530621 CMS
Otsuka America Pharmaceutical, Inc. $21.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1119098692 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.